The arrival of IL-6 also enhances breast CSC migration, promotes tumor growth and metastasis [258], and induces angiogenesis by inducing the expression of proangiogenic molecules, such as VEGF, MMP2 and MMP9 [259,260]. Here, IL6 is linked to neoplasm.